Summary
Selection of labeled 18F-molecules for the production of 18F-radioligands to image enzyme and GPCR targets within the Janssen Neuroscience portfolio. IMAp will be involved in the design of radioligands to support JANSSEN CNS drug discovery programs involving ESR3.
More information & hyperlinks